Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report
-
- Katsuhisa Sekido
- Department of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City Japan
-
- Shuichi Imaue
- Department of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City Japan
-
- Kei Tomihara
- Department of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City Japan
-
- Hidetake Tachinami
- Department of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City Japan
-
- Kentaro Yamagishi
- Department of Radiology Faculty of Medicine University of Toyama Toyama City Japan
-
- Seisuke Okazawa
- First Department of Internal Medicine Faculty of Medicine University of Toyama Toyama City Japan
-
- Atsushi Ikeda
- Department of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City Japan
-
- Kumiko Fujiwara
- Department of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City Japan
-
- Makoto Noguchi
- Department of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City Japan
抄録
<jats:title>Abstract</jats:title><jats:p>Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective.</jats:p>
収録刊行物
-
- Clinical Case Reports
-
Clinical Case Reports 9 (9), 2021-08-30
Wiley